Navigation Links
Dr. Taub to give Estabrook Research Lecture at Kessler Foundation on Nov. 28
Date:11/6/2012

West Orange, NJ. November 6, 2012. Kessler Foundation announces that The 2012 Estabrook Distinguished Research Lectureship will be given on November 28, 2011 at Kessler Conference Center, 1199 Pleasant Valley Way in West Orange, New Jersey, from 12 noon to 1:30 pm. Edward Taub, PhD, will lecture on "Constraint-induced (CI) Therapy: A Family of Treatments in Rehabilitation that Remodel the Brain." Dr. Taub is director of the CI Therapy Research Group and Taub Training Clinic at the University of Alabama at Birmingham and a professor in the Department of Psychology.

Registration is complimentary, but reservations are required. Light refreshments are included. Register for the Estabrook Lecture now!

Dr. Taub, a noted behavioral neuroscientist, developed constraint-Induced therapy, which has been shown to be effective in improving movement after stroke, traumatic brain injury, multiple sclerosis, and other neurological injuries. In this intervention, the unaffected limb is immobilized, encouraging use of the weakened limb. CI therapy produces an increase in grey matter tissue in motor areas in the cerebral cortex of both hemispheres a true remodeling of the brain. This occurs in older patients as well as children, indicating that the plasticity of the brain persists throughout the life span. Grey matter in the hippocampus also increases, indicating that the creation of new nerve cells may be involved in the therapeutic effects produced by CI therapy.

Dr. Taub has received numerous awards for his research, which has been called one of the ten most exciting lines of neuroscience research. Nearly 400 papers have been published on the effects of CI therapy.


'/>"/>

Contact: Carolann Murphy
CMurphy@KesslerFoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. Research could lead to preeclampsia prevention
2. Researchers discover immune pathway
3. Temple researchers show targeted cancer drug may stunt hearts ability to repair itself
4. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
5. Researchers discover how underground rodent wards off cancer
6. New research suggests standardized booster seat laws could save lives of children
7. Medical care presents update on pharmaceutical health services research
8. Penn Medicines Daniel J. Rader, M.D., receives AHAs Clinical Research Prize
9. 23andMe demonstrates comprehensive research capabilities at annual meeting for ASHG
10. New research on employment-based insurance sheds light on health care reform
11. Forum to bring together leading-edge ophthalmic researchers and investors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
Breaking Medicine Technology: